We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A baby laying down.

No Adverse Health Risks From Steroids Used for Pre-Term Birth, Study Finds

Immunotherapy attacking a cancer cell.

Immunotherapy Combination Approved for Non-Muscle Invasive Bladder Cancer

Two white mushrooms.

Psilocybin Shows Promise for Treatment-Resistant Depression – But Is It Safe?

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

News

Daiichi Sankyo to Acquire Ambit Biosciences

Lead compound, quizartinib, will further build Daiichi Sankyo oncology pipeline.

Johnson & Johnson Announces Agreement to Acquire Alios BioPharma

Acquisition strengthens existing pipeline in viral diseases.

WuXi PharmaTech Laboratory Testing Division Expands in U.S.

XenoBiotic acquisition expands LTD’s presence in North America.

Exco InTouch Shortlisted for the Best Technological Development in Clinical Trials 2014 SCRIP Award

Selection for the accolade shortlist recognizes the company’s mDNA® technology project team - leading the way with innovation in the field of patient engagement and data capture solutions to enhance efficiencies in clinical trials.

EpiCypher™ Awards Five Epigenetic Research Grants

EpiCypher’s first annual grant program funds 5 histone modification research projects.

Novartis Announces Clinical Collaboration with Bristol-Myers Squibb

Collaboration highlights promising new treatment approach for patients and underscores Novartis' commitment to patients and the lung cancer community.

Horizon Discovery Group Signs Co-Exclusive Commercial Agreement with Haplogen Genomics

Adds high-throughput, low cost CRISPR/Cas9 human haploid cell line generation service and extensive human haploid knock-out cell lines catalog.

Study Finds Potential New Target to Treat Asthma Attacks Brought on by Colds

Results suggest that IL-25 could be a target for possible treatments to prevent asthma attacks.

Sigmoid Enters Into a License Agreement with Pendopharm

Exclusive license agreement to commercialize CyCol® for ulcerative colitis in Canada.

nLife Therapeutics Receives USD 350,000 from The Michael J. Fox Foundation

The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter